Skip to main content
Select Search Option
Menu
Weill Cornell Medicine
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
Richard T. Silver MD Myeloproliferative Neoplasms Center
Richard T. Silver MD Myeloproliferative Neoplasms Center
Explore this Website
  • Home
  • For Patients
    • Conditions
      • Chronic Myeloid Leukemia
      • Essential Thrombocythemia
      • Myelofibrosis
      • Polycythemia Vera
      • Chronic Eosinophilic Leukemias
      • MDS/MPN
      • MPN-Unclassifiable
      • Mastocytosis
    • Complications
      • Bleeding
      • Cardiovascular Disease (heart failure, pulmonary artery hypertension)
      • Depression and other mood disorders
      • Diarrhea and other gastrointestinal complications
      • Pregnancy and MPNs
      • Pruritus (Itching)
      • Thrombosis/Blood Clots
      • Sexual Dysfunction
    • Treatments
      • Anagrelide (Agrylin®)
      • Anti-Coagulants
      • Aspirin
      • Bone Marrow Transplant
      • Bosutinib (Bosulif®)
      • Clopidogrel (Plavix®)
      • DNA Hypomethylating Agents (DHAs)
      • Dasatinib (Sprycel®)
      • Erythropoiesis-Stimulating Agents (ESAs)
      • Hydroxyurea
      • Imatinib (Gleevec®)
      • Interferons
      • Lenalidomide (Revlimid®)
      • Nilotinib (Tasigna®)
      • Phosphorous-32
      • Ponatinib (Iclusig®)
      • Prednisone
      • Ruxolitnib
      • Tyrosine Kinase Inhibitors (TKIs)
    • Frequently Asked Questions
    • Resources
    • Your First Visit
    • Request an Appointment
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations
      • Essential Thrombocythemia (ET)
  • News and Updates
    • Events
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
  • Home
  • For Patients
  • For Professionals
  • News and Updates
  • Research and Clinical Trials
  • About Us
  • Home
  • How Specialized Treatment Changed Dave’s Polycythemia V(...)

How Specialized Treatment Changed Dave’s Polycythemia Vera Experience

How Specialized Treatment Changed Dave’s Polycythemia Vera Experience

In 2006, Dave Boule was diagnosed with polycythemia vera, a type of myeloproliferative neoplasm (MPN) that affects blood cell production in the body. After starting phlebotomy treatment, his platelets and red blood cell counts continued to rise, and he started doing research into other options for therapies that might be more effective. This research led him to Dr. Richard T. Silver at Weill Cornell Medicine.

Read more...

Our Location
Richard T. Silver MD Myeloproliferative Neoplasms Center
Contact Us
  • Twitter
  • Facebook
  • YouTube
520 E 70th Street Starr Pavillion, 341
New York, NY 10021
Phone: (646) 962-2727
Fax: (646) 962-0115
  • For Patients
    • Conditions
      • Chronic Myeloid Leukemia
      • Essential Thrombocythemia
      • Myelofibrosis
      • Polycythemia Vera
      • Chronic Eosinophilic Leukemias
      • MDS/MPN
      • MPN-Unclassifiable
      • Mastocytosis
    • Complications
      • Bleeding
      • Cardiovascular Disease (heart failure, pulmonary artery hypertension)
      • Depression and other mood disorders
      • Diarrhea and other gastrointestinal complications
      • Pregnancy and MPNs
      • Pruritus (Itching)
      • Thrombosis/Blood Clots
      • Sexual Dysfunction
    • Treatments
      • Anagrelide (Agrylin®)
      • Anti-Coagulants
      • Aspirin
      • Bone Marrow Transplant
      • Bosutinib (Bosulif®)
      • Clopidogrel (Plavix®)
      • DNA Hypomethylating Agents (DHAs)
      • Dasatinib (Sprycel®)
      • Erythropoiesis-Stimulating Agents (ESAs)
      • Hydroxyurea
      • Imatinib (Gleevec®)
      • Interferons
      • Lenalidomide (Revlimid®)
      • Nilotinib (Tasigna®)
      • Phosphorous-32
      • Ponatinib (Iclusig®)
      • Prednisone
      • Ruxolitnib
      • Tyrosine Kinase Inhibitors (TKIs)
    • Frequently Asked Questions
    • Resources
    • Your First Visit
    • Request an Appointment
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations
      • Essential Thrombocythemia (ET)
  • News and Updates
    • Events
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.
Weill Cornell Medicine NewYork - Presbyterian
© Weill Cornell Medicine.
  • Privacy & Legal
  • Careers
  • Giving
  • Directory
  • Web Accessibility Assistance